When Consent Isn’t Enough – The TTAB’s Decision in In re Ye Mystic Krewe of Gasparilla
NFTs on Trial: The Yuga Labs Verdict and What It Means for the Digital Frontier — The Crypto Exchange Podcast
(Podcast) The Briefing: When Consent Isn’t Enough – The TTAB’s Decision in In re Ye Mystic Krewe of Gasparilla
The Briefing: Protecting Fictional Characters – Copyright and Trademark Strategies
Top Employment Insights: 44th Annual Workforce Management Briefing - #WorkforceWednesday® - Employment Law This Week®
(Podcast) The Briefing: Protecting Fictional Characters – Copyright and Trademark Strategies
The Briefing: The Nirvana Baby Lawsuit – A Win for Nirvana
The IP Future: Intellectual Property Challenges in AI Health Care Contracts – The Good Bot: Artificial Intelligence, Health Care, and the Law
BYTES: Multimodal Versus Unimodal AI
BYTES: Open Source Software
SkadBytes Podcast | The EU Data Act: How New Rules Could Reshape Access, Control and Competition in the Data Economy
Unexpected Paths to IP Law with Jerry Hrycyszyn and Suresh Rav
(Podcast) The Briefing: The Nirvana Baby Lawsuit – A Win for Nirvana
Can a Coach's Playbook Be Copyrighted? — No Infringement Intended Podcast
Partner Craig Seebald Explains Day 1 of a Criminal Antitrust Investigation
Partner Nicole Castle Explains Vinson & Elkins' Antitrust Cartel Primer
Partner Jason Powers Explains Vinson & Elkins' Antitrust Cartel Primer
It Only Took 13 Years: The Federal Circuit's First Derivation Proceeding Decision — Patents: Post-Grant Podcast
The Briefing: Studios Beware – The Danger of the Beauty and the Beast Copyright Decision
(Podcast) The Briefing - Studios Beware: The Danger of the Beauty and the Beast Copyright Decision
Lewis Brisbois v. Bitgood et al., No. 24-20458 (5th Cir. 2025) - In an unpublished per curiam opinion, the Fifth Circuit affirmed a permanent injunction against a trio of defendants, rejected an attorney immunity defense,...more
When Dr. Stephen Thaler asked the U.S. Supreme Court to reconsider the human authorship requirement for copyright protection last month, many observers dismissed the effort. Thaler’s claim—that his generative AI system should...more
The following is a hypothetical story meant for general educational purposes and is not based on any real-life business or dispute. Readers should consult an attorney prior to taking action to determine how this information...more
The Secretary of War Pete Hegseth announced on November 7, 2025, that the U.S. Department of War (DOW) is dropping a game-changing memo: “Transforming the Warfighting Acquisition System to Accelerate Fielding of...more
District court denies motion to dismiss plaintiffs’ claim of direct copyright infringement based on AI outputs, holding that plaintiffs adequately pled that defendant OpenAI actually copied plaintiffs’ text and that...more
Key Takeaways - The Federal Circuit upheld the USPTO director’s discretion to deny IPRs, rejecting due process and APA challenges to the agency’s evolving policy framework....more
I. INTRODUCTION - Brand license agreements can drive business growth and brand recognition. By granting rights to use, develop, and commercialize technology and other IP (such as trademarks), license agreements enable...more
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., Nos. 2025-1210, -1211 (Fed. Cir. (P.T.A.B.) Oct. 30, 2025). Opinion by Linn, joined by Hughes and Cunningham. Merck owns two patents directed to methods of treating...more
The Federal Circuit Court of Appeals’ recent decision in Focus Products Group International, LLC v. Kartri Sales Co., Inc., No. 2023-1446 (Fed. Cir. Sept. 30, 2025) reversed summary judgment of infringement on two patents and...more
In a seemingly otherwise run-of-the-mill, albeit precedential, decision, the Federal Circuit affirmed a stipulated judgment of non-infringement in Aortic Innovations LLC v. Edwards Lifesciences Corp....more
With the advent of claim fees in 2022, applicants must now limit the number of claims in their Canadian patent applications to avoid government fees. While cancelling claims (particularly dependent claims) is the simplest...more
On November 6, 2025, Amgen, Inc. (“Amgen”) launched a new round of BPCIA denosumab litigations when it filed two cases in the U.S. District Court for the District of New Jersey, one against Dr. Reddy’s Laboratories (“Dr....more
Technologies such as Wi-Fi, 5G and 4G LTE, and high-fidelity video streaming are ubiquitous in modern products. In fact, a huge portion of everyday technologies is based on technical standards like these, and that portion is...more
The court has reminded brand owners that position trade marks must comprise a single identifiable sign, and cannot be left open-ended by broad written descriptions. Fashion brand Thom Browne applied for declarations of...more
Recently, the USPTO published a rare Appeals Review Panel (ARP) decision in Ex parte Desjardins, Appeal 2024-000567, September 26, 2025 (“ARP Decision”), that reversed a finding of ineligible subject matter in a patent...more
On October 29, 2025, the U.S. Food and Drug Administration (FDA), in coordination with the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS), announced a new strategy aimed...more
Want to learn more about drafting, negotiating, and understanding intellectual property and technology contracts and have 10 minutes to spare? Grab your morning coffee or afternoon tea and dig into our Tech Contract Quick...more
“Maple washing” and “maple glazing” are buzzwords gaining traction online and in the news, reflecting a rise in Canadian-inspired marketing of a wide variety of goods and services across the country....more
Drag is a form of performance art in which individuals use clothing, makeup, and exaggerated mannerisms to express and perform aspects of gender identity, often through parody, glamor, or camp. It can take many forms—from...more
Aerospace technology companies often decide between patenting an innovation or keeping it as a trade secret. Typically, the analysis involves comparing the potential strength of patent protection that is likely to result. If...more
In a trio of rulings on Nov. 6, 2025, the Federal Circuit delivered a clear message: discretionary denial of Inter Partes Review (IPR) petitions is unreviewable on appeal. The court will not interfere with the U.S. Patent and...more
On October 3, 2025, in its decision in Philips v. Belkin (UPC_CoA_534/2024, UPC_CoA_19/2025, UPC_CoA_683/2024), the Court of Appeal (CoA) of the Unified Patent Court (UPC) addressed for the first time the circumstances under...more
Whether you are a veteran partner or a first-year associate, preparing for a Markman hearing can be stressful. You may be done filing the briefs, but you have other things to contend with, such as refining the arguments,...more
Share on LinkedIn Share on Twitter Share by Email Share Back to top There has been a great deal of discussion surrounding the current artificial intelligence (AI) boom, as well as the potential for a bust reminiscent of the...more
Trade secrets are a critical tool for protecting medical technology innovations. To that end, a robust trade secret management program is essential for safeguarding these valuable assets. To be effective in today’s legal...more